======= CDC37 ======= == Gene Information == * **Official Symbol**: CDC37 * **Official Name**: cell division cycle 37 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=11140|11140]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q16543|Q16543]] * **Interactions**: [[https://thebiogrid.org/search.php?search=CDC37&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20CDC37|Open PubMed]] * **OMIM**: [[https://omim.org/entry/605065|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Co-chaperone that binds to numerous kinases and promotes their interaction with the Hsp90 complex, resulting in stabilization and promotion of their activity (PubMed:8666233). Inhibits HSP90AA1 ATPase activity (PubMed:23569206). {ECO:0000269|PubMed:23569206, ECO:0000269|PubMed:8666233}. |CDC37 C| |CDC37 M| |CDC37 N| |HSP90-CDC37 chaperone complex| |positive regulation of mitophagy in response to mitochondrial depolarization| |positive regulation of mitophagy| |protein kinase regulator activity| |chaperone complex| |positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization| |regulation of autophagy of mitochondrion in response to mitochondrial depolarization| |regulation of mitophagy| |response to mitochondrial depolarisation| |positive regulation of autophagy of mitochondrion| |regulation of interferon-gamma-mediated signaling pathway| |regulation of response to interferon-gamma| |ERBB2 signaling pathway| |regulation of type I interferon-mediated signaling pathway| |Hsp90 protein binding| |regulation of autophagy of mitochondrion| |heat shock protein binding| |scaffold protein binding| |positive regulation of macroautophagy| |ERBB signaling pathway| |kinase binding| |regulation of cyclin-dependent protein serine/threonine kinase activity| |chaperone binding| |regulation of cyclin-dependent protein kinase activity| |positive regulation of mitochondrion organization| |positive regulation of autophagy| |unfolded protein binding| |regulation of cytokine-mediated signaling pathway| |regulation of macroautophagy| |regulation of response to cytokine stimulus| |protein stabilization| |regulation of mitochondrion organization| |protein folding| |regulation of protein stability| |regulation of autophagy| |protein targeting| |positive regulation of cellular catabolic process| |positive regulation of catabolic process| |regulation of innate immune response| |protein kinase binding| |transmembrane receptor protein tyrosine kinase signaling pathway| |regulation of protein serine/threonine kinase activity| |regulation of response to biotic stimulus| |posttranscriptional regulation of gene expression| |positive regulation of organelle organization| |enzyme linked receptor protein signaling pathway| |regulation of defense response| |regulation of multi-organism process| |regulation of protein kinase activity| |regulation of cellular catabolic process| |regulation of kinase activity| |regulation of transferase activity| |regulation of catabolic process| |intracellular protein transport| |regulation of response to external stimulus| |regulation of immune response| |regulation of cell cycle| |positive regulation of cellular component organization| |regulation of organelle organization| |regulation of protein phosphorylation| |regulation of response to stress| |protein transport| |intracellular transport| |peptide transport| |amide transport| |cellular protein localization| |regulation of phosphorylation| |cellular macromolecule localization| |establishment of protein localization| |regulation of immune system process| |cellular response to stress| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |establishment of localization in cell| |regulation of protein modification process| |nitrogen compound transport| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp231|Epothilone-B 0.0015μM R05 exp231]]|-2.21| |[[:results:exp434|Vemurafenib 6.6μM R08 exp434]]|-2.17| |[[:results:exp272|CHIR-124 0.04μM R06 exp272]]|-2.03| |[[:results:exp489|Hippuristanol 0.12μM R08 exp489 no dilution day6]]|-2.03| |[[:results:exp515|PU-H71 1μM R08 exp515]]|-1.96| |[[:results:exp102|Nifuroxazide 5μM R03 exp102]]|-1.94| |[[:results:exp29|Rapamycin 1μM R00 exp29]]|-1.94| |[[:results:exp233|EPZ-5676 30μM R05 exp233]]|-1.92| |[[:results:exp458|Bisphenol S 100μM R08 exp458]]|-1.89| |[[:results:exp334|All-trans-Retinoic-Acid 40μM R07 exp334]]|-1.86| |[[:results:exp3|Actinomycin-D 0.001μM R00 exp3]]|-1.85| |[[:results:exp502|Milciclib 2μM R08 exp502]]|-1.84| |[[:results:exp242|Radicicol 0.16μM R05 exp242]]|-1.83| |[[:results:exp530|Thioridazine 5μM R08 exp530]]|-1.83| |[[:results:exp316|Geldanamycin 0.015 to 0.025μM on day4 R07 exp316]]|-1.78| |[[:results:exp486|Heregulin-B 44ng/ml R08 exp486]]|-1.76| |[[:results:exp283|Glyphosate 1000μM R06 exp283]]|-1.74| |[[:results:exp460|BML-284 0.09μM R08 exp460]]|-1.73| |[[:results:exp277|Curcumin 6.5μM R06 exp277]]|-1.72| |[[:results:exp234|Ethanol 0.01 R05 exp234]]|-1.72| |[[:results:exp121|Golgicide-A 2μM R03 exp121]]|-1.72| |[[:results:exp208|Vinblastine 0.015μM R05 exp208]]|1.71| |[[:results:exp256|HMS-I1 10μM R06 exp256]]|2.21| ^Gene^Correlation^ |[[:human genes:f:fntb|FNTB]]|0.427| |[[:human genes:m:med16|MED16]]|0.402| Global Fraction of Cell Lines Where Essential: 528/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|1/1| |909776.0|1/1| |bile duct|23/28| |blood|21/28| |bone|18/26| |breast|27/33| |central nervous system|36/56| |cervix|4/4| |colorectal|15/17| |esophagus|10/13| |fibroblast|0/1| |gastric|14/16| |kidney|13/21| |liver|13/20| |lung|46/75| |lymphocyte|11/16| |ovary|18/26| |pancreas|17/24| |peripheral nervous system|12/16| |plasma cell|10/15| |prostate|1/1| |skin|15/24| |soft tissue|5/9| |thyroid|0/2| |upper aerodigestive|18/22| |urinary tract|17/29| |uterus|3/5| == Essentiality in NALM6 == * **Essentiality Rank**: 633 * **Expression level (log2 read counts)**: 7.6 {{:chemogenomics:nalm6 dist.png?nolink |}}